OVID
OVID clinical trials: Ovid Therapeutics Inc.
Every trial on ClinicalTrials.gov where Ovid Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 3
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
OVID on the catalyst calendar · OVID registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 2, 2020Actual | NCT04106557A Study of OV101 in Individuals With Angelman Syndrome (AS)Ovid Therapeutics Inc. · Primary Disease or Condition Being Studied: Angelman Syndrome (AS) | OVIDLead | Phase 3 | Completed | Locked | Locked | Locked |
| Feb 3, 2020Actual | NCT03697161A Study of OV101 in Individuals With Fragile X SyndromeOvid Therapeutics Inc. · Fragile X Syndrome (FXS) | OVIDLead | Phase 2 | Completed | Locked | Locked | Locked |
| Nov 28, 2017Actual | NCT03109756Single Dose Pharmacokinetic (PK) StudyOvid Therapeutics Inc. · Angelman Syndrome | OVIDLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Nov 2, 2020ActualPhase 3NCT04106557A Study of OV101 in Individuals With Angelman Syndrome (AS)Ovid Therapeutics Inc. · Primary Disease or Condition Being Studied: Angelman Syndrome (AS)CompletedOVIDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 3, 2020ActualPhase 2NCT03697161A Study of OV101 in Individuals With Fragile X SyndromeOvid Therapeutics Inc. · Fragile X Syndrome (FXS)CompletedOVIDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 28, 2017ActualPhase 1NCT03109756Single Dose Pharmacokinetic (PK) StudyOvid Therapeutics Inc. · Angelman SyndromeCompletedOVIDLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner